Leveraging homologous recombination repair deficiency in sarcoma
Abstract Personalised oncology is at the forefront of cancer research. The goal of personalised oncology is to selectively kill cancer cells while minimising side effects on normal tissue. This can be achieved by identifying and targeting cancer vulnerabilities that distinguish it from normal cells....
| Autori principali: | , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Springer Nature
2023-03-01
|
| Serie: | EMBO Molecular Medicine |
| Accesso online: | https://doi.org/10.15252/emmm.202317453 |